In human parainfluenza virus type 2 (hPIV-2)-infected cells, anti-phosphoprotein (P)-specific monoclonal antibody (MAb) densely stained the perinuclear regions of infected cells throughout infection, indicating that the P protein was localized exclusively in the cell cytoplasm. By contrast, antigens recognized by MAbs directed against the P-V-common domain of hPIV-2 were located predominantly in the cytoplasm, but in some hPIV-2-infected cells they were also found in the nuclei, suggesting that a fraction ofhPIV-2 V protein is localized there, hPIV-2 V protein expressed from a cDNA clone was localized in the nuclei of transfected cells. By using indirect immunofluorescence analyses, we examined the intracellular localization of various sequentially deleted V proteins, to determine the nuclear localization signals (NLS) of the V protein. Two noncontiguous regions in the V protein were required for nuclear localization and retention, since deletion of these regions [region I (aa 1-46) and region II (aa ] resulted in cytoplasmic localization. Both regions resulted in nuclear localization independently. A nucleoplasmin-like NLS was identified in region II but no consensus targeting sequence could be found in region I. When NP protein was co-expressed with V protein or the Nterminal fragment (aa 1-46) of V protein, a fraction of the NP protein was translocated into cell nuclei.
Introduction
Human parainfluenza virus type 2 (hPIV-2) is a negativestrand RNA virus, a member of the family Paramyxoviridae, and a major human respiratory pathogen (Pringle, 1991) . The six structural proteins, nucleocapsid (NP), phosphoprotein (P), matrix (M), fusion (F), haemagglutinin-neuraminidase (HN) and large (L) proteins, are encoded by the virus genome in that order (Yuasa et al., 1990) . The P protein of paramyxoviruses is an indispensable polypeptide which has a direct role in the transcription and replication of the genome RNA in co-operation with L protein (RNA polymerase) (Hamaguchi et al., 1983) . The paramyxovirus P gene also encodes other small polypeptides, V, C and C' (Thomas et al., 1988; Dethlefsen & Kolakofsky, 1983; Giorgi et al., 1983) . Ohgimoto et al. (1990) reported that the hPIV-2 P gene encodes the V protein and that P protein mRNA is produced by addition of two nontemplated G residues, resulting in a frameshift. The V protein is a structural protein in simian virus 5 (SV5) (Thomas et al., * Author for correspondence. Fax +81 592 31 5008. e-mail ito @doc.medic.mie-u.ac.jp 1988), simian virus 41 (SV41) (Kawano et al., 1993) , mumps virus (MuV) (Takeuchi et al., 1988) and hPIV-2 (Ohgimoto et al., 1990) , but a nonstructural protein in Sendai virus (Dethlefsen & Kolakofsky, 1983; Giorgi et al., 1983) and measles virus (MV) (Bellini et al., 1985) .
Very little is known about the function of V protein. In MV, the V protein is responsible for zinc binding and competes with P protein for L protein binding (Liston & Briedis, 1994) . However, Smallwood et al. (1994) reported that V protein does not contain a binding site for L protein. Paterson et al. (1995) reported that SV5 V protein binds two atoms of zinc and is a structural component of virions. As regards intracellular localization of V protein, the MV and Sendai virus V proteins are evenly distributed throughout the cytoplasm of infected cells (Curran et al., 1991b; Wardrop & Briedis, 1991) , and the SV5 V protein is present in both the nuclei and the cytoplasm (Paterson et al., 1995) .
In this study we found that hPIV-2 V protein expressed from a cDNA clone is located in the nuclei of transfected cells. Furthermore, we identified by deletion analysis the sequences responsible for transport of the hPIV-2 V protein into the nucleus. Our results indicate that two regions are required for nuclear localization and retention, and that they have independent roles.
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Methods
Viruses, cells and plasmids, hPIV-2 (Toshiba strain), recombinant vaccinia virus expressing T7 RNA polymerase (VVT7) [kindly donated by B. Moss (Fuerst et al., 1986) ] and HeLa CD4 + cells [kindly donated by Y. Takebe (NIH, Tokyo, Japan)], were used in this study, hPIV-2 V gene cDNAs were cloned as described previously (Ohgimoto et al., 1990) .
Construction of deletion mutants and MuV NP chimeras. PCR was used to create V or P gene deletion mutants. The sequences of oligonucleotides used in PCR are listed in Fig. 1 . Of these, six (1) (2) (3) (4) (5) 16) contain extra nucleotides, a XhoI site, primer 17 and a SalI site, whereas the rest contain a PstI site. A stop codon (TAA) was also incorporated in the 3' end of three primers (8, 10 and 12) . Each 3' primer was paired with the 5' primer to produce the required mutant by PCR. The mutant encoding V(1-164) was synthesized using cDNA templates and PCR primers 1 and 8. Similarly, the mutant encoding V(47 174) was synthesized using primers 2 and 10, V(4~196) using primers 2 and 12, V(1-164)-NP using primers 1 and 7, V(165 225)-NP using primers 4 and 15, V(47 164) NP using primers 2 and 7, V(lll 164) NP using primers 3 and 7, V(1 46) NP using primers 1 and 6, V(165 206) NP using primers 4 and 11, V(165-196)-NP using primers 4 and 13, V(175-225)-NP using primers 5 and 15, V(175 206) NP using primers 5 and 11, V(175-196)-NP using primers 5 and 13, V(47 174~NP using primers 2 and 9, and V(47-196) NP using primers 2 and 11. V(1 164), V(47-174) and V(47-196) were individually inserted into pBluescript vector.
To construct deletion mutants encoding V plus MuV NP chimeras, the mutants encoding V infected with VVT7. At 1 h post infection (p.i.) the defined cells were transfected with the various plasmids (1 lag each), as indicated in the figure legends, by lipofection and incubated at 37 °C in minimal essential medium (MEM). At 2 h post-transfection (p.t.), the medium was replaced with MEM containing 5 % fetal calf serum (FCS). At (~24 h p.t. HeLa CD4 + cells were fixed with 10 % formaldehyde in PBS for 20 rain, washed with PBS, and treated with acetone at 20 °C for 20 min. Samples were stored at 4 °C until stained. Fixed cells were analysed by indirect immunofluorescence staining with monoclonal antibodies (MAbs) raised against hPIV-2 P/V, hPIV-2 P, hPIV-2 NP and MuV NP (Tanabayashi et al., 1990; Tsurudome et al., 1989 Tsurudome et al., , 1990 . All the recombinants were tested in at least two different experiments.
Establishment of HeLa cell lines which constitutively express the SV41
Vprotein. A cDNA clone of the SV41 V gene was inserted into plasmid pcDL-SR~ 296 between the PstI and KpnI sites. The cDNA fragment was inserted between the ClaI and SalI sites of the vector pkan2 (41V-pkan2). Plasmid pkan2 contains the G418 (Geneticin; GIBCO) resistance gene. The promoter in pkan2 is identical to the SR~ promoter (SV40 + ATL promoters). HeLa cells were grown in 90 mm dishes at 37 °C in MEM containing 5 % FCS. The cells were washed twice with warm MEM, and then transfected with plasmids 41V-pkan2 in 4 ml of MEM with Lipofectin (GIBCO). After incubation for 8 h at 37 °C, MEM with 10 % calf serum was added. After incubation for a further 2 days the culture medium was changed to MEM containing 10% FCS, 1 mg/ml Geneticin and 0.1% agarose, and the cells were cultured for about 3 weeks. Expression of the SV41 V protein was detected by ELISA with the SV41 P/V-specific MAb. Since cell selection may occur in the colony isolation procedure used to isolate cell lines expressing the virus proteins, six transfectant cell lines were analysed in this study. Plasmid pcDL-SR~ 296 and pkan2 plasmids were kindly donated by Y. Takebe (NIH, Tokyo, Japan) (Takebe et al., 1988) . Subcellular Jractionation. HeLa CD4 + cells were transfected with various cDNA clones and then fractionated by a method similar to that described by Briedis et al. (1981) . Briefly, cells were detached mechanically and collected by centrifugation. The cells were lysed by vortexing for 4 s in a buffer containing 0.5% NP40, 0.5% Triton X-100, 0.2 % sodium deoxycholate, 10 mM-Tris-HCl (pH 7.2), 140 mMNaCI and 1"5 mM-MgC12, and incubated at 0 °C for 30 min. After centrifugation at 600 g for 5 min, the pellet was designated as the nuclear fraction and the supernatant as the cytoplasmic fraction. The nuclear pellet was then washed twice in the same buffer and lysed by sonification. All fractions were analysed by SDS-PAGE and Western blotting.
Results
Intracellular localization of the hPIV-2 P and V proteins
HeLa CD4 + cells were infected with hPIV-2, and at appropriate time points the cells were fixed and then immunostained with MAbs specific for hPIV-2 P or P/V proteins. The anti-P MAb densely stained the perinuclear regions of infected cells in granular patterns at all time points, indicating that the P protein was localized exclusively in the cytoplasm (Fig. 2a) . By contrast, although antigens recognized by MAbs directed against the P-V-common domain of hPIV-2 were detected in the cytoplasm, in a small fraction of hPIV-2-infected cells, diffuse nuclear staining was observed at early time points V protein is present not only in the cytoplasm but also in the nuclei of the cells.
Intracellular localization of the P and V proteins expressed from cDNA clones
To ascertain the nuclear localizing potential of the hPIVdetected in the cytoplasm, whereas the V protein was present in the nuclei and cytoplasm of transfected cells.
These findings indicate that when the V protein is expressed without any other virus-specific protein, it is found not only in the cytoplasm but also in the nuclei of cells. As a negative control, cells transfected with cDNA corresponding to mRNA encoding the hPIV-2 NP protein were immunostained with MAbs specific for hPIV-2 P/V or P. These cells showed no specific fluorescence [(Fig. 2a, panels (v) and (vi)].
To establish the subcellular distribution of the V protein, cells transfected with cDNA corresponding to mRNA encoding the hPIV-2 P or V protein were fractionated into cytoplasmic and total nuclear fractions, and these were analysed by SDS-PAGE and Western blotting with a MAb specific for hPIV-2 P/V. The P protein was present only in the cytoplasm, and the V protein in the nuclei and cytoplasm (Fig. 2 b) . There was no difference between the results obtained by cell fractionation compared with those obtained by indirect immunofluorescence analysis. Therefore, the subsequent experiments were done by indirect immunofluorescence.
Expression of V gene deletion mutants
The candidate nuclear localization signal (NLS) sequence(s) in the V protein was examined by constructing several general deletion mutants in the V protein cDNA. Mutants were constructed by PCR, using oligonucleotide primers, and cloned into pBluescript. HeLa CD4 + cells were transfected with each deletion construct, and at 2 h p.t. the intracellular location of each mutated protein was analysed by indirect immunofluorescent staining. When there was no suitable MAb against hPIV-2 P/V (the products encoded by deletion mutants did not react with any hPIV-2 P/V-specific MAb available in our laboratory), cDNA encoding the C-terminal region of MuV NP protein was added to the 3' terminus of each deletion mutant (positive sense) and consequently chimeric proteins were generated.
Deletion mutants encoding the P-V-common domain and V-specific domain.
Two deletion mutants in the V protein cDNA were constructed: a deletion mutant encoding the P-V-common domain (aa 1-164) and the V-specific domain (aa 165-225). As shown in Fig. 3 , the V(1 164)-NP mutated protein, in which the V protein lacks the C-terminal 61 aa and is fused with MuV NP, was detected mainly in the nuclei, and the V(165-225) NP mutated protein, in which the specific domain of V protein is fused with MuV NP, was also detected mainly in the nuclei of transfected cells. However, there is a possibility that localization of these mutated proteins in the nuclei was a consequence of sequences responsible for the nuclear targeting of MuV NP. To eliminate this possibility, the intracellular distribution of the MuV NP protein was studied, cDNA encoding the C-terminal region of MuV NP protein (aa 474-549) was synthesized by PCR using primers 16 and 17 (see Fig. 1 ), and was then tailed with dG and inserted into a dC-tailed plasmid vector (pBluescript). The intracellular localization was studied with MAbs directed against the C-terminal region of MuV NP, showing that the MuV NP protein was located in the cell cytoplasm [ (Fig. 3b, panel (iii) ]. Thus the localization pattern of these mutated proteins reflects the inherent properties of hPIV-2 encoded domains and does not result from the MuV NP part of the protein. NLSs are defined, in part, by their ability to target a normally cytoplasmic protein to the nucleus. Thus two regions certainly cause the cytoplasmic protein, MuV NP, to be translocated to the nucleus. As a negative control, cells transfected with cDNA corresponding to mRNA encoding the hPIV-2 NP protein were stained with a MAb specific for MuV NP. These cells showed no specific fluorescence [ (Fig. 3 b, (Fig. 6a,  b) . By contrast, V(1-46)-NP and V(175 196) NP were detected predominantly in the nuclei at 3 h p.t. (Fig. 6c,  e ), but by 8 h p.t. were predominantly localized in the cytoplasm (Fig. 6d, J) . These results suggest that both regions I and II are required for retention of the V protein in the nuclei.
detected in the nuclei and cytoplasm of transfected cells (Fig. 7g) . Subsequently, the NP gene cDNA was cotransfected together with deletion mutants encoding the P V-common domain or V-specific domain, and the localization of these proteins was studied. When NP protein was co-expressed with the P-V-common domain, V(1-164)-NP, NP protein was detected in the cytoplasm and nuclei of transfected cells (Fig. 7h) . By contrast, when NP protein was co-expressed with the V-specific domain, V(165-225)-NP, NP protein was localized predominantly in the cell cytoplasm ( Fig. 7 I" ). Even when NP protein was expressed together with V(1-46)-NP, NP protein was detected not only in the cytoplasm, but also in the nuclei of transfected cells (Fig. 7j) , suggesting that NP protein interacts with the N-terminal region of V protein and is consequently translocated to the nuclei. Co-expression of NP and P proteins resulted in their localization in the cytoplasm (Fig. 7k) .
Intracellular localization of the NP protein when coexpressed with the P / V protein or deleted V proteins
In virus-infected cells, V protein does not exist in isolation but co-exists with other virus-specific proteins. Therefore, the hPIV-2 V and NP proteins were coexpressed and their intracellular localization was examined ( Fig. 7) . When NP protein was expressed from a cDNA clone without any virus-specific protein, it was detected in the cytoplasm (Fig. 7/) , whereas when NP protein was co-expressed with V protein, NP protein was
Expression of P gene deletion mutants
The hPIV-2 P protein was localized in the cytoplasm of transfected or hPIV-2-infected cells. However, the P Vcommon domain of the P protein expressed from a cDNA clone was detected in the nuclei of transfected cells. Therefore, we constructed mutated proteins lacking either the N-terminal or C-terminal region of the P protein, and studied their intracellular distribution. The N-terminal 110 aa deleted protein was detected in the cytoplasm of transfected cells [ (Fig. 8 a, 
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deleted P protein, lacking the C-terminal 115 aa of P protein, was detected in the cytoplasm and nuclei [(Fig. 8 a, panel (ii) ], suggesting that the C-terminal half of the P-specific domain can compete with, but not completely cancel, the nuclear-targeting potential of the N-terminal region of the P protein.
Intracellular localization of the SV41 V protein
To investigate whether the V proteins of paramyxoviruses other than hPIV-2 were also capable of localizing in the nuclei, we expressed transiently or constitutively the SV41 V protein in HeLa cells. The SV41 V protein was localized in the nuclei of transfected cells (Fig. 8) , indicating that the V proteins ofparamyxoviruses, especially those belonging to the parainfluenza virus type 2 group, can target the nuclei of cells.
Discussion
In this study we found that the hPIV-2 V protein was localized in the nuclei of transfected cells. Since pores in the nuclear envelope have a functional radius of 4.5 nm, it is thought that proteins with a molecular mass of less than 67 kDa can diffuse through them passively (Paine et al., 1975) . The V protein has a molecular mass 32 kDa and theoretically could diffuse passively into the nucleus. However, if diffusion alone accounted for the cellular location of the V protein, it would be distributed equally throughout the cell rather than accumulating in any one compartment. Also, the part of the MuV NP protein used in this study has a molecular mass of about 8 kDa and is localized in the cytoplasm. Therefore, the V protein contains sequence information that codes for its nuclear localization. The data presented in this paper demonstrate that the functioning of two regions ] is required for the nuclear localization of the hPIV-2 V protein, and that these two regions play independent roles. Deletion of both regions abolished the ability of the protein to be translocated into the nucleus, but polypeptides containing each region alone could be targeted into the nucleus and later transferred to the cytoplasm. By contrast, both regions were necessary for efficient nuclear targeting and to retain the V protein in the nuclei, Nuclear proteins accumulate in cell nuclei because they contain NLSs that allow selective entry through the nuclear pore complex (Dingwall & Laskey, 1986; Roberts, 1989) . NLSs consisting of short stretches of basic amino acids have been identified for many proteins, Most of these sequences fall into two general categories of NLS: (1) a 'single cluster' containing 3-5 basic amino acids, or (2) a 'bipartite' sequence containing two interdependent clusters of basic amino acids separated by an intervening sequence. The NLS in the SV40 large T antigen remains the best characterized example of an NLS belonging to the 'single cluster' category. 'Bipartite' NLSs have been identified in several nuclear proteins including influenza virus PA (Nieto et al., 1994) , PB1 (Nath & Nayak, 1990) , PB2 (Mukaigawa & Nayak, 1991) and NS1 (Greenspan et al., 1988) , nucleoplasmin (Robbins et al., 1991) and human papillomavirus type 16 L1 protein (Zhou et al., 1991) . For paramyxoviruses, Paterson et al. (1995) reported that SV5 V protein was found in the nuclei and cytoplasm of infected cells; Yoshida et al. (1976) were able to stain the nuclei of Sendai virus-infected cells with a monospecific antiserum raised against the M protein; Hamaguchi et al. (1985) and Peeples (1987) reported that MAbs to the M protein of Newcastle disease virus (NDV) also stained the nuclei of infected cells; and Coleman & Peeples (1993 ) reported that the NDV M protein was found in the nuclei and an NLS consisting of two interdependent basic amino acid clusters resided in the M protein between positions 247-263.
Region I in the P-V-common domain does not belong to any known category of NLS. Rather, a sequence similar to the NLS of SV40 large T antigen, which was sufficient to promote nuclear accumulation of a reporter protein (Kalderon et al., 1984) , exists downstream (aa 67-72) of the N-terminal region, but the sequence was not involved in nuclear localization of the V protein. Roberts et at. (1987) reported that basic sequences similar to those of known NLSs are present in a number of non-nuclear proteins. For example, capsid protein VP3 of poliovirus type I contains the sequence Pro-ProLys-Lys-Arg-Lys-Glu (Smith et al., 1985) . In this and other similar cases, the potential nuclear localizing activity of the basic sequence appears to be masked.
Region II of hPIV-2 V protein has little similarity to any known bipartite NLS, e.g. nucleoplasmin, which consists of two essential regions of basic amino acids that function in an interdependent manner and a 10 aa 'spacer' region that separates the two basic regions (Robbins et al., 1991) . Region II contains a basic pair (arginine) at aa 175 and 176 and a basic amino acid (lysine) at aa 188, and the spacing between the two regions is 11 aa. In addition, since removal of 4 aa from the intervening sequence in the nucleoplasmin NLS destroyed nuclear localization (Dingwall et al., 1988) , the spacing between components of this bipartite NLS is considered to be important. The number of amino acids separating the basic components of bipartite NLSs is most often 10 or 13 (Coleman & Peeples, 1993) . However, deletions of amino acids from the intervening sequences of influenza virus PB1 or BS II/BS III of adenovirus DNA polymerase had no effect on nuclear localization (Nath & Nayak, 1990; Zhao & Padmanabhan, 1991) and insertion of amino acids in the intervening regions has generally been found not to disrupt nuclear localization (Robbins et al., 1991 ; Schreiber et al., 1992; Yuasa et al., 1990) .
The secondary structure of the NLS region is predicted to be a-helical (Garnier, 1978) . Coleman & Peeples (1993) reported that the nucleoplasmin, N1, opaque-2 proteins and the NDV M protein are predicted by use of the Garnier algorithm to be predominantly c~-helical throughout their bipartite NLS, and that the poly(ADP-ribose) polymerase, VirD2 and human papillomavirus type 16 L1 proteins are all predicted to be c~-helical within the C-terminal portions of their sequences only. However, region II and the V protein C terminus are predicted not to contain a-helical structures. The V protein C terminus consists of a cysteine-rich region that is highly conserved in canine distemper virus, Sendai virus, hPIV-3 and MuV (Ohgimoto et al., 1990) . Thomas et al. (1988) reported that the cysteine-rich region bore some resemblance to metal-binding proteins with a zinc finger-type motif. Mullen et al. (1994) reported that the cysteine-rich zinc finger region may have some limited nuclear localization targeting characteristics in herpes simplex virus. However, we found that the cysteine-rich region of hPIV-2 V protein had no nuclear localization potential.
Although the hPIV-2 P protein (aa 1 280) contains region I, which has nuclear targeting activity, it is localized in the cytoplasm of infected and transfected cells. A deleted P protein lacking the C-terminal 115 aa is located predominantly in the cytoplasm, but partly in the nucleus. In addition, a deleted protein lacking the N-terminal 110 aa was found in the cytoplasm, indicating that if the C terminus of the P protein was present, region I might not work efficiently. It is inferred that the C terminus of the P protein plays a role as the anchor that retains the P protein in the cytoplasm. The SV40 amino acid sequences that can act as NLSs may not always function because their activity is sensitive to the structural environment within which they are present in any given protein (Roberts et al., 1987) . The putative NLS present in poliovirus VP3 may be masked by interaction with other fractions of the poliovirus virion (Smith et aL, 1985) . Region I of the V/P protein is a weak nuclear localization signal which is influenced by the other regions.
The function of and requirement for the hPIV-2 V protein are not known, and the significance of its localization in the nucleus is uncertain. Since members of the family Paramyxoviridae undergo genomic replication, mRNA transcription, protein synthesis and assembly of virus components in the cytoplasm, the V proteins may not be essential for virus production; they may influence host factors. The Sendai virus V protein is not only non-essential, but also inhibitory to virus replication (Curran et al., 1991b (Curran et al., , 1994 . However, Curran et al. (1994) also reported that the V protein had a slightly stimulatory effect on Sendai virus transcription in vitro. The NDV M protein, which localizes in the nucleus, may be involved in the inhibition of host protein synthesis (Peeples et al., 1992) . Investigating the V protein NLS is important when analysing its function. Intriguingly, when NP proteins are co-expressed with V proteins, a fraction of the NP protein is localized in the nuclei of transfected cells. This suggests that V proteins can bind NP protein and modify its function. Paterson et al. (1995) reported that V protein may be directly in contact with the ribonucleoprotein (RNP) complex or may associate with a specific subclass of M protein which in turn is associated with the RNP. Although the biological significance of the nuclear localization of hPIV-2 V protein remains unclear, there are at least two possibilities: (1) the V protein in nuclei may play a role in the inhibition of nuclear function that is part of the cytopathology of hPIV-2 infection; (2) the V proteins can bind to NP protein and may modify its function.
